A multi-database, multinational validation study of cardiovascular death, venous thromboembolic events and gastrointestinal diseases in the EU-ADR Alliance

A multi-database, multinational validation study of cardiovascular death, venous thromboembolic events and gastrointestinal diseases in the EU-ADR Alliance

Bibliografske podrobnosti
Main Authors:	Ying, H, Reyes, C, Lapi, F, Simonetti, M, Rijnbeek, P, Van Der Lei, J, Marinier, K, Deltour, N, Alhambra, D
Format:	Conference item
Izdano:	Elsevier 2018

Podobne knjige/članki

Impact of risk minimisation measures on the use of strontium ranelate: A multinational cohort study in 5 EU countries by the EU‐ADR Alliance
od: Berencsi, K, et al.
Izdano: (2018)

Impact of risk minimisation measures on the use of strontium ranelate: a multi-national cohort study in 5 EU countries by the EU-ADR Alliance
od: Berencsi, K, et al.
Izdano: (2017)

Comparative cardiovascular safety of strontium ranelate and bisphosphonates amongst patients with no contraindications: A multi‐database study in 5 EU countries by the EU‐ADR Alliance
od: Ali, M, et al.
Izdano: (2018)

Comparative cardiovascular safety of strontium ranelate and bisphosphonates amongst patients with no contraindications: a multi-database study in our European countries by the EU-ADR Alliance
od: Ali, M, et al.
Izdano: (2017)

Osteoporosis and venous thromboembolism: a retrospective cohort study in the UK General Practice Research Database.
od: Breart, G, et al.
Izdano: (2010)

Osteoporosis and venous thromboembolism: a retrospective cohort study in the UK General Practice Research Database.
od: Breart, G, et al.
Izdano: (2010)

Patient characteristics of new initiators of glycopyrronium bromide (GLY) – A multinational, multi-database real-world drug-utilization study
od: Verhamme, K, et al.
Izdano: (2016)

Multinational strategic alliances /
od: 340670 Mockler, Robert J.
Izdano: (1999)

STRONTIUM RANELATE AND RISK OF VENOUS THROMBOEMBOLISM (VTE): AN UPDATE OF A RETROSPECTIVE COHORT STUDY IN THE UK GENERAL PRACTICE RESEARCH DATABASE (GPRD)
od: Cooper, C, et al.
Izdano: (2012)

Risk of venous thromboembolism amongst users of different antiosteoporosis drugs: a multinational population-based cohort study
od: Martin-Merino, E, et al.
Izdano: (2016)

Multinational, database cohort study to study mortality and risk factors of mortality in patients with asthma
od: Verhamme, K, et al.
Izdano: (2016)

Risk of venous thromboembolism amongst users of different anti-osteoporosis drugs: a multinational population-based cohort study
od: Martin-Merino, E, et al.
Izdano: (2016)

Venous thromboembolism still leads on maternal death
od: Amelia Shard, et al.
Izdano: (2025-01-01)

Causes of death after first time venous thromboembolism
od: Frida Lonnberg, et al.
Izdano: (2024-02-01)

Venous thromboembolic events following cytoreductive surgery for lower gastrointestinal neoplasia
od: Mina Guirgis, et al.
Izdano: (2024-09-01)

Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry
od: Behnood Bikdeli, et al.
Izdano: (2022-01-01)

Venous thromboembolism
od: Wang Chunmei
Izdano: (2024-07-01)

Adult breast, lung, pancreatic, upper and lower gastrointestinal cancer patients with hospitalized venous thromboembolism in the national French hospital discharge database
od: F. Couturaud, et al.
Izdano: (2023-06-01)

Tranexamic Acid in Upper Gastrointestinal Bleeding is Associated With Venous and Arterial Thromboembolic Events
od: Cosmo Fowler, MD, et al.
Izdano: (2024-03-01)

Value of neutrophil to lymphocyte ratio in the prognosis of death of patients with venous thromboembolism
od: Mojtaba Zare Ebrahimabad, et al.
Izdano: (2017-11-01)

Asian venous thromboembolism guidelines: updated recommendations for the prevention of venous thromboembolism
od: Liew, Ngoh Chin, et al.
Izdano: (2017)

Venous thromboembolism in cancer surgery: A report from the nationwide readmissions database
od: Chelsea S. Pan, BA, et al.
Izdano: (2022-07-01)

Could sodium imbalances predispose to postoperative venous thromboembolism? An analysis of the NSQIP database
od: Sally Temraz, et al.
Izdano: (2018-07-01)

Venous thromboembolic complications
od: G. G. Khubulava, et al.
Izdano: (2019-02-01)

THALASSEMIA AND VENOUS THROMBOEMBOLISM
od: Julien Succar, et al.
Izdano: (2011-05-01)

THALASSEMIA AND VENOUS THROMBOEMBOLISM
od: Khaled M. Musallam, et al.
Izdano: (2011-01-01)

Osteoporosis and venous thromboembolism
od: Irina Aleksandrovna Baranova, et al.
Izdano: (2011-02-01)

Preeclampsia and venous thromboembolism
od: K. N. Grigoreva, et al.
Izdano: (2022-07-01)

Hyperglycemia and Venous Thromboembolism
od: Neha Panchagnula, et al.
Izdano: (2024-09-01)

Venous anomalies and thromboembolism
od: Caroline Dix, et al.
Izdano: (2023-04-01)

Approach to: Venous Thromboembolism
od: Salima Ramdani
Izdano: (2022-10-01)

Venous Thromboembolism in Adolescents
od: Aneta Samková, et al.
Izdano: (2012-01-01)

Venous thromboembolism and pregnancy
od: Maristella D&rsquo;Uva, et al.
Izdano: (2010-03-01)

Venous thromboembolism in Cushing syndrome: results from an EuRRECa and Endo-ERN survey
od: M Cherenko, et al.
Izdano: (2024-05-01)

Venous Thromboembolic Complications in Pediatric Gastrointestinal Diseases: Inflammatory Bowel Disease and Intestinal Failure
od: Renz C. W. Klomberg, et al.
Izdano: (2022-04-01)

Partial knee replacement is associated with a lower risk of venous thromboembolism and opioid use than total knee replacement but increased risk of long-term revision: a multinational, multi-database, propensity score-matched, cohort analysis including over 280,000 patients
od: Prieto-Alhambra, D, et al.
Izdano: (2019)

Multinational cohort study of mortality in patients with asthma and severe asthma
od: Engelkes, M, et al.
Izdano: (2020)

Adres łaciński
od: Jerzy A. Wojtczak-Szyszkowski
Izdano: (2023-09-01)

Risk and timing of venous thromboembolism in patients with gastrointestinal cancer: a nationwide Danish cohort study
od: Gunnar Hilmar Gislason, et al.
Izdano: (2023-01-01)

Estimate of venous thromboembolism and related-deaths attributable to the use of combined oral contraceptives in France.
od: Aurore Tricotel, et al.
Izdano: (2014-01-01)